Rafael Holdings at Guggenheim conference touts npc drug despite trial miss

🌐 Investing.com (Cyprus) —
Rafael Holdings at Guggenheim conference touts npc drug despite trial miss

AI Summary

Rafael Holdings promoted its NPC drug candidate at a Guggenheim conference despite a miss in a clinical trial. The article provides no further details about the trial or the drug.

Markets Health Rafael Holdings NPC drug clinical trial drug development Guggenheim conference

Read original source →